Search Results - "Cohen, Isaac V."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis by Makunts, Tigran, Cohen, Isaac V., Awdishu, Linda, Abagyan, Ruben

    Published in Scientific reports (19-02-2019)
    “…Proton pump inhibitors, PPIs, are widely prescribed and sold globally. Although initially intended for time-limited treatment of acute disorders, such as…”
    Get full text
    Journal Article
  2. 2

    Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database by Cohen, Isaac V., Makunts, Tigran, Abagyan, Ruben, Thomas, Kelan

    Published in Scientific reports (16-03-2021)
    “…3,4-Methylenedioxymethamphetamine (MDMA) is currently being evaluated by the Food and Drug Administration (FDA) for the treatment of post-traumatic stress…”
    Get full text
    Journal Article
  3. 3

    Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data by Makunts, Tigran, Saunders, Ila M., Cohen, Isaac V., Li, Mengxing, Moumedjian, Talar, Issa, Masara A., Burkhart, Keith, Lee, Peter, Patel, Sandip Pravin, Abagyan, Ruben

    Published in Scientific reports (30-08-2021)
    “…Antibodies targeting the PD-1, PD-L1, and CTLA-4 immune checkpoint axis have been used in a variety of tumor types. They achieve anti-tumor activity through…”
    Get full text
    Journal Article
  4. 4

    Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications by Cohen, Isaac V., Makunts, Tigran, Atayee, Rabia, Abagyan, Ruben

    Published in Scientific reports (03-05-2017)
    “…Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for…”
    Get full text
    Journal Article
  5. 5

    Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain by Makunts, Tigran, Cohen, Isaac V, Lee, Kelly C, Abagyan, Ruben

    Published in PloS one (18-04-2018)
    “…Currently approved monoamine modulating antidepressant and anxiolytic pharmaceutics fail in over one third of patients due to delayed and variable therapeutic…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Publisher Correction: Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications by Cohen, Isaac V., Makunts, Tigran, Atayee, Rabia, Abagyan, Ruben

    Published in Scientific reports (05-12-2017)
    “…A correction to this article has been published and is linked from the HTML version of this paper. The error has not been fixed in the paper…”
    Get full text
    Journal Article
  8. 8

    Acetaminophen (Paracetamol) Use Modifies the Sulfation of Sex Hormones by Cohen, Isaac V., Cirulli, Elizabeth T., Mitchell, Matthew W., Jonsson, Thomas J., Yu, James, Shah, Naisha, Spector, Tim D., Guo, Lining, Venter, J. Craig, Telenti, Amalio

    Published in EBioMedicine (01-02-2018)
    “…Acetaminophen (paracetamol) is one of the most common medications used for management of pain in the world. There is lack of consensus about the mechanism of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports by Cohen, Isaac V., Makunts, Tigran, Moumedjian, Talar, Issa, Masara A., Abagyan, Ruben

    Published in Scientific reports (05-11-2020)
    “…Chloroquine (CQ) and hydroxychloroquine (HCQ) are on the World Health Organization’s List of Essential Medications for treating non-resistant malaria,…”
    Get full text
    Journal Article